NCT03576885
Inhaled Nitric Oxide Treatment of Extremely Preterm Infants with Delayed Pulmonary Vascular Transition to Reduce the Incidence of Broncho-pulmonary Dysplasia
Associated Conditions
Neonatal, PulmonarySponsor
Mallinckrodt Company
This research is being conducted to see if using inhaled nitric oxide (a gas that is delivered along with oxygen) in extremely preterm infants with pulmonary hypertension will decrease the long-term lung problems and improve their outcomes.
This study is currently enrolling.